Urine-based markers in bladder cancer: Future prospects

BJU International

Volumn 101, Issue 6, 2008, Pages 668-669

  McNeil, Brian K ^a   Getzenberg, Robert H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIN RECEPTOR; NUCLEAR MATRIX PROTEIN 22; SCATTER FACTOR RECEPTOR; SURVIVIN; TRANSCRIPTION FACTOR PAX6;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CELL PROLIFERATION; DISEASE COURSE; DNA METHYLATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE IDENTIFICATION; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TUMOR XENOGRAFT; URINE; URINE CYTOLOGY;

FORECASTING; HUMANS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 39449101617     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07439.x     Document Type: Note

References (10)

1. American Cancer Society. Cancer Facts and Figures 2007. Available at: http://www.cancer.org/docroot/STT/content/STT_1x_Cancer_FactsFigures_2007.asp. Accesssed November 2007
2. Rife CC, Farrow GM, Utz DC. Urine cytology of transitional cell neoplasms. Urol Clin North Am 1979 6 : 599 612
3. Nielsen ME, Schaeffer EM, Veltri RW, Schoenberg MP, Getzenberg RH. Urinary markers in the detection of bladder cancer: what's new? Curr Opin Urol 2006 16 : 350 5
4. Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM. Survivin: a promising tumor biomarker. Cancer Lett 2007 249 : 49 60
5. Shariat SF, Casella R, Khoddami SM et al. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 2004 171 : 626 30
6. Davies B, Chen J, Modugno F et al. Contribution of the prostate limits the usefulness of survivin for the detection of bladder cancer. J Urol 2005 174 : 1767 70
7. Gonzalgo ML, Datar RH, Schoenberg MP, Cote RJ. The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer. Urol Oncol 2007 25 : 228 35
8. Athauda G, Giubellino A, Coleman JA et al. c-Met ectodomain shedding rate correlates with malignant potential. Clin Cancer Res 2006 12 : 4154 62
9. Getzenberg RH, Konety BR, Oeler TA et al. Bladder cancer-associated nuclear matrix proteins. Cancer Res 1996 56 : 1690 4
10. Van Le TS, Miller R, Barder T, Babjuk M, Potter DM, Getzenberg RH. Highly specific urine-based marker of bladder cancer. Urology 2005 66 : 1256 60